Cutter Capital Management, LP Sarepta Therapeutics, Inc. Transaction History
Cutter Capital Management, LP
- $244 Billion
- Q4 2024
A detailed history of Cutter Capital Management, LP transactions in Sarepta Therapeutics, Inc. stock. As of the latest transaction made, Cutter Capital Management, LP holds 124,256 shares of SRPT stock, worth $13.3 Million. This represents 6.19% of its overall portfolio holdings.
Number of Shares
124,256
Previous 83,756
48.35%
Holding current value
$13.3 Million
Previous $10.5 Billion
44.43%
% of portfolio
6.19%
Previous 3.09%
Shares
4 transactions
Others Institutions Holding SRPT
# of Institutions
535Shares Held
87.4MCall Options Held
1.55MPut Options Held
1.35M-
Black Rock Inc. New York, NY10.3MShares$1.1 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.09MShares$970 Million0.02% of portfolio
-
Capital International Investors Los Angeles, CA8.7MShares$928 Million0.21% of portfolio
-
Janus Henderson Group PLC London, X04.33MShares$462 Million0.28% of portfolio
-
State Street Corp Boston, MA4.07MShares$434 Million0.02% of portfolio
About Sarepta Therapeutics, Inc.
- Ticker SRPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 87,567,904
- Market Cap $9.35B
- Description
- Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...